Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Carbon Monoxide for Stable COPD
NCT00122694Phase 2Completed
- Sponsor
- Groningen Research Institute for Asthma and COPD
- Start
- Jan 2005
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Carbon monoxide in chronic obstructive pulmonary disease (COPD), sponsored by Groningen Research Institute for Asthma and COPD. Started Jan 2005; status: completed.
02
Drugs
Carbon monoxide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00122694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00122694.